Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Krystal Biotech (KRYS) Other Gross PP&E Adjustments: 2021-2025

Historic Other Gross PP&E Adjustments for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $164.2 million.

  • Krystal Biotech's Other Gross PP&E Adjustments fell 2.07% to $164.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $659.9 million, marking a year-over-year decrease of 0.08%. This contributed to the annual value of $168.1 million for FY2024, which is 5.37% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Other Gross PP&E Adjustments is $164.2 million, which was up 0.09% from $164.1 million recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Other Gross PP&E Adjustments peaked at $168.1 million during Q4 2024, and registered a low of $32.4 million during Q1 2021.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $164.2 million (2025), whereas its average is $164.2 million.
  • In the last 5 years, Krystal Biotech's Other Gross PP&E Adjustments skyrocketed by 298.23% in 2022 and then fell by 2.07% in 2025.
  • Over the past 5 years, Krystal Biotech's Other Gross PP&E Adjustments (Quarterly) stood at $105.4 million in 2021, then surged by 45.10% to $153.0 million in 2022, then climbed by 4.31% to $159.6 million in 2023, then climbed by 5.37% to $168.1 million in 2024, then dropped by 2.07% to $164.2 million in 2025.
  • Its last three reported values are $164.2 million in Q3 2025, $164.1 million for Q2 2025, and $163.4 million during Q1 2025.